U.S. approval of pharma companies' COVID-19 vaccine development handling 2021

Published by
Matej Mikulic,
Oct 14, 2022
According to a survey conducted in March 2021 among U.S. adults, around 75 percent of respondents stated that they either strongly approve or somewhat approve of how pharmaceutical companies handled the development of the COVID-19 vaccinations. This statistic illustrates the percentage of U.S. likely voters who approve of how pharmaceutical companies handled COVID-19 vaccine development.

Percentage of U.S. adults who approve of how pharmaceutical companies handled COVID-19 vaccine development as of 2021

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

April 2021

Region

United States

Survey time period

March 24-26, 2021

Number of respondents

1,225 respondents

Age group

18 years and older

Special properties

likely voters

Method of interview

Online survey

Supplementary notes

Original question: "Do you approve or disapprove of how pharmaceutical companies like Pfizer, Moderna, and Johnson & Johnson handled vaccine development in response to the pandemic?"

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " U.S. pharmaceutical industry "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you U.S. pharmaceutical industry

Contribution to global pharma

5

Overview

6

Companies

6

Research and development

7

Generics

5

Public view on pharma

6

Outlook

4

Further related statistics

18

Further Content: You might find this interesting as well

Statistics

Topics

Pharmaceutical research and development (R&D)Global pharmaceutical industryPharmaceutical industry in the U.S.Top pharmaceutical drugsCoronavirus (COVID-19) vaccines and treatments
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.